Aragen Life Sciences (Aragen), formerly known as GVK Biosciences and a leading contract research organization (CRO), announced that Goldman Sachs, an active investor in India, has taken a significant minority stake in the company by acquiring shares previously held by ChrysCapital and other existing shareholders. Aragen is a leading provider of outsourced discovery, development, and…
Hyderabad, Andhra Pradesh, India and Newtown, PA, United States, Wednesday, January 09, 2013: GVK BIO, Asia’s leading Contract Research and Development organization and Onconova Therapeutics, a U.S. based biopharmaceutical company primarily focused on discovery and development of novel small molecules for Oncology, today announced that they have entered into a novel joint partnership to develop…